The overexpression and aberrant glycosylation of MUC1 is associated with a wide variety of cancers, making it an ideal target for immunotherapeutic strategies. This review highlights the main avenues of research in this field, focusing on adenocarcinomas, from the preclinical to clinical; the problems and possible solutions associated with each approach; and speculates on the direction of MUC1 immunotherapeutic research over the next 5-10 years.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/imt.10.17 | DOI Listing |
Publication Analysis
Top Keywords
muc1 immunotherapy
4
immunotherapy overexpression
4
overexpression aberrant
4
aberrant glycosylation
4
glycosylation muc1
4
muc1 associated
4
associated wide
4
wide variety
4
variety cancers
4
cancers making
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!